Ingo Sprie's practice focuses on complex litigation, including class actions, mass torts, product liability, and significant business disputes. He has substantial experience defending putative class actions, cases employing novel claim aggregation theories, and cases involving cutting-edge theories of liability. He has litigated cases in state and federal courts around the country. He is experienced in coordinating multi-jurisdictional litigation and addressing problems that require the coordination of litigation, legislative, and public relations solutions. Mr. Sprie serves on the Board of Directors of New York Lawyers for the Public Interest, a leading pro bono organization in New York City.


  • Ongoing defense of pharmaceutical company in hundreds of cases brought by governmental entities seeking to recover alleged public health and safety expenditures related to opioids.
  • Defense of pharmaceutical company in RICO action to recover monies spent by third-party payers in providing coverage for certain medications, defeating class certification and prevailing on summary judgment.
  • Defense of consumer products company in connection with thousands of personal injury cases filed in the aftermath of a decertified class action in state and federal courts in Florida. These cases presented numerous significant issues of law, including issues concerning class actions, collateral estoppel, due process, and federal preemption.
  • Representation of power company in obtaining dismissal of putative class action asserting claims for property damage and medical monitoring related to toxic spill.
  • Defense of manufacturers of welding rods (and alleged successors to such companies) in obtaining dismissal of claims that they engaged in a conspiracy and acted in concert through trade associations to conceal the hazards of their products.
  • Defense of pharmaceutical company in thousands of personal injury and medical monitoring cases concerning diet drugs. Involved in all aspects of federal MDL litigation, as well as defense of individual suits.
  • Defense of alleged successor to a manufacturer of lead pigment in dozens of cases brought in Louisiana, Massachusetts, Missouri, New York, Ohio, Pennsylvania, Texas, and elsewhere. These cases included putative class actions and other suits by governmental entities seeking abatement of lead paint in private and public buildings, as well as reimbursement of alleged health care and abatement expenditures. They also included putative medical monitoring class actions and individual personal injury cases. Obtained dismissal of all cases prior to trial.
  • Defense of automobile manufacturers and consumer products companies in numerous putative class actions alleging breach of warranty and consumer fraud.
  • Representation of consumer products company in obtaining declaration that company did not assume various environmental liabilities for former industrial sites under the terms of a contractual indemnity.
  • Representation of insurance brokerage company in connection with class actions relating to "contingent commission" practices and asserting claims for customer allocation, price-fixing, and tying under federal and state antitrust statutes, as well as claims under the Racketeer Influenced and Corrupt Organizations Act and common law theories of breach of fiduciary duty and unjust enrichment.


The Legal 500 US
Product Liability and Mass Tort Defense: Consumer Products (including tobacco) (2013, 2015)


  • JD, Harvard Law School, 1986, cum laude
  • BA, Johns Hopkins University, 1983, with honors
  • New York
  • New Jersey
  • US Court of Appeals for the Second Circuit
  • US Court of Appeals for the Eleventh Circuit
  • US District Court, Eastern District of New York
  • US District Court, Southern District of New York
  • US District Court, District of New Jersey
  • Supreme Court of New Jersey, The Honorable Marie L. Garibaldi

Email Disclaimer